These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28976859)

  • 1. Challenges in the Design and Interpretation of Noninferiority Trials.
    Mauri L; D'Agostino RB
    N Engl J Med; 2017 Oct; 377(14):1357-1367. PubMed ID: 28976859
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.
    Hong J; Tung A; Kinkade A; Tejani AM
    J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004
    [No Abstract]   [Full Text] [Related]  

  • 3. Interpretation and inference in noninferiority randomized controlled trials in drug research.
    Wangge G; Klungel OH; Roes KC; de Boer A; Hoes AW; Knol MJ
    Clin Pharmacol Ther; 2010 Sep; 88(3):420-3. PubMed ID: 20668448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: Systematic reviewers face challenges from varied study designs.
    Altman DG
    BMJ; 2002 Aug; 325(7362):461. PubMed ID: 12211227
    [No Abstract]   [Full Text] [Related]  

  • 5. An orwellian discourse on the meaning and measurement of noninferiority.
    Diamond GA; Kaul S
    Am J Cardiol; 2007 Jan; 99(2):284-7. PubMed ID: 17223435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.
    Pincus T
    Adv Mind Body Med; 2002; 18(2):14-21. PubMed ID: 12629874
    [No Abstract]   [Full Text] [Related]  

  • 7. A bootstrap-based test for establishing noninferiority in clinical trials.
    Chen M; Kianifard F; Dhar SK
    J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
    Kaul S; Diamond GA
    Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.
    Aberegg SK; Hersh AM; Samore MH
    J Gen Intern Med; 2018 Jan; 33(1):88-96. PubMed ID: 28875400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
    Trafimow D; Rice S
    Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinician's guide to the assessment and interpretation of noninferiority trials for novel therapies.
    Oczkowski SJ
    Open Med; 2014; 8(2):e67-72. PubMed ID: 25009686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basics of designing a clinical trial: part II.
    Whitney JD
    J Wound Ostomy Continence Nurs; 2000 Nov; 27(6):293-5. PubMed ID: 11096408
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: The debate on non-inferiority trials: 'when meta-analysis alone is not helpful'.
    Liberati A; D'Amico R
    Int J Epidemiol; 2010 Dec; 39(6):1582-3. PubMed ID: 21113051
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiplicity in oncology randomised controlled trials: a threat to medical evidence?
    Prasad V; Booth CM
    Lancet Oncol; 2019 Dec; 20(12):1638-1640. PubMed ID: 31797779
    [No Abstract]   [Full Text] [Related]  

  • 17. Separation of health and statistics.
    Church TR
    J Natl Cancer Inst; 2008 Apr; 100(7):452-3. PubMed ID: 18364500
    [No Abstract]   [Full Text] [Related]  

  • 18. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.
    Luce BR; Kramer JM; Goodman SN; Connor JT; Tunis S; Whicher D; Schwartz JS
    Ann Intern Med; 2009 Aug; 151(3):206-9. PubMed ID: 19567619
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.
    Soonawala D; Middelburg RA; Egger M; Vandenbroucke JP; Dekkers OM
    Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinding during data analysis and writing of manuscripts.
    Gøtzsche PC
    Control Clin Trials; 1996 Aug; 17(4):285-90; discussion 290-3. PubMed ID: 8889343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.